<VariationArchive RecordType="classified" VariationID="2573281" VariationName="NM_003001.5(SDHC):c.107_108del (p.Glu36fs)" VariationType="Deletion" Accession="VCV002573281" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-21" DateCreated="2023-07-29" MostRecentSubmission="2023-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2738229" VariationID="2573281">
      <GeneList>
        <Gene Symbol="SDHC" FullName="succinate dehydrogenase complex subunit C" GeneID="6391" HGNC_ID="HGNC:10682" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="161314381" stop="161363206" display_start="161314381" display_stop="161363206" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="161284165" stop="161334540" display_start="161284165" display_stop="161334540" Strand="+" />
          </Location>
          <OMIM>602413</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SDHC">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SDHC">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_003001.5(SDHC):c.107_108del (p.Glu36fs)</Name>
      <CanonicalSPDI>NC_000001.11:161328424:AA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="161328425" stop="161328426" display_start="161328425" display_stop="161328426" variantLength="2" positionVCF="161328424" referenceAlleleVCF="GAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="161298215" stop="161298216" display_start="161298215" display_stop="161298216" variantLength="2" positionVCF="161298214" referenceAlleleVCF="GAA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>E17fs</ProteinChange>
      <ProteinChange>E36fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.161298215_161298216del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.161298215_161298216del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.161328425_161328426del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.161328425_161328426del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012767.1" sequenceAccession="NG_012767" sequenceVersion="1" change="g.19050_19051del">
            <Expression>NG_012767.1:g.19050_19051del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001035511.3" sequenceAccession="NM_001035511" sequenceVersion="3" change="c.107_108del">
            <Expression>NM_001035511.3:c.107_108del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001030588.1" sequenceAccession="NP_001030588" sequenceVersion="1" change="p.Glu36fs">
            <Expression>NP_001030588.1:p.Glu36fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407115.1" sequenceAccession="NM_001407115" sequenceVersion="1" change="c.107_108del">
            <Expression>NM_001407115.1:c.107_108del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394044.1" sequenceAccession="NP_001394044" sequenceVersion="1" change="p.Glu36fs">
            <Expression>NP_001394044.1:p.Glu36fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407116.1" sequenceAccession="NM_001407116" sequenceVersion="1" change="c.50_51del">
            <Expression>NM_001407116.1:c.50_51del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394045.1" sequenceAccession="NP_001394045" sequenceVersion="1" change="p.Glu17fs">
            <Expression>NP_001394045.1:p.Glu17fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407117.1" sequenceAccession="NM_001407117" sequenceVersion="1" change="c.50_51del">
            <Expression>NM_001407117.1:c.50_51del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394046.1" sequenceAccession="NP_001394046" sequenceVersion="1" change="p.Glu17fs">
            <Expression>NP_001394046.1:p.Glu17fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407119.1" sequenceAccession="NM_001407119" sequenceVersion="1" change="c.-5_-4del">
            <Expression>NM_001407119.1:c.-5_-4del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407120.1" sequenceAccession="NM_001407120" sequenceVersion="1" change="c.-5_-4del">
            <Expression>NM_001407120.1:c.-5_-4del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407121.1" sequenceAccession="NM_001407121" sequenceVersion="1" change="c.50_51del">
            <Expression>NM_001407121.1:c.50_51del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394050.1" sequenceAccession="NP_001394050" sequenceVersion="1" change="p.Glu17fs">
            <Expression>NP_001394050.1:p.Glu17fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003001.5" sequenceAccession="NM_003001" sequenceVersion="5" change="c.107_108del" MANESelect="true">
            <Expression>NM_003001.5:c.107_108del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002992.1" sequenceAccession="NP_002992" sequenceVersion="1" change="p.Glu36fs">
            <Expression>NP_002992.1:p.Glu36fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_103459.3" sequenceAccession="NR_103459" sequenceVersion="3" change="n.132_133del">
            <Expression>NR_103459.3:n.132_133del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001035512.3" sequenceAccession="NM_001035512" sequenceVersion="3" change="c.77+4755_77+4756del">
            <Expression>NM_001035512.3:c.77+4755_77+4756del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278172.3" sequenceAccession="NM_001278172" sequenceVersion="3" change="c.77+4755_77+4756del">
            <Expression>NM_001278172.3:c.77+4755_77+4756del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407118.1" sequenceAccession="NM_001407118" sequenceVersion="1" change="c.77+4755_77+4756del">
            <Expression>NM_001407118.1:c.77+4755_77+4756del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001035513.3" sequenceAccession="NM_001035513" sequenceVersion="3" change="c.21-12169_21-12168del">
            <Expression>NM_001035513.3:c.21-12169_21-12168del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_317" sequenceAccession="LRG_317">
            <Expression>LRG_317:g.19050_19051del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_317t1" sequenceAccession="LRG_317t1">
            <Expression>LRG_317t1:c.107_108del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_317p1" sequenceAccession="LRG_317p1" change="p.Glu36Glyfs">
            <Expression>LRG_317p1:p.Glu36Glyfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003001.5(SDHC):c.107_108del (p.Glu36fs) AND Paragangliomas 3" Accession="RCV003316970" Version="1">
        <ClassifiedConditionList TraitSetID="1968">
          <ClassifiedCondition DB="MedGen" ID="C1854336">Paragangliomas 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-07-29" MostRecentSubmission="2023-07-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1968" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5732" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Paragangliomas 3</ElementValue>
                <XRef ID="Paragangliomas+3/5580" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011544" DB="MONDO" />
                <XRef Type="MIM" ID="605373" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glomus tumors, familial, 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SDHC-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome (Paragangliomas 3)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 3</ElementValue>
                <XRef Type="MIM" ID="605373" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602413.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602413.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602413.0001" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPGL3</ElementValue>
                <XRef Type="MIM" ID="605373" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PGL3</ElementValue>
                <XRef Type="MIM" ID="605373" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas cause catecholamine excess; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base and neck (referred to as head and neck PGL [HNPGL]) and sometimes in the upper mediastinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically lead to catecholamine excess. Symptoms of PGL/PCC result from either mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for developing metastatic disease is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas.</Attribute>
                <XRef ID="NBK1548" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10545" />
                <XRef ID="10545" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301715</ID>
                <ID Source="BookShelf">NBK1548</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2009">
                <ID Source="pmc">2668639</ID>
              </Citation>
              <Citation Type="review">
                <ID Source="PubMed">20816580</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2014">
                <ID Source="PubMed">24893135</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCRNC, 2013">
                <ID Source="PubMed">24319509</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <XRef ID="29072" DB="Orphanet" />
              <XRef ID="C1854336" DB="MedGen" />
              <XRef ID="MONDO:0011544" DB="MONDO" />
              <XRef Type="MIM" ID="605373" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7519804" SubmissionDate="2023-07-25" DateLastUpdated="2023-07-29" DateCreated="2023-07-29">
        <ClinVarSubmissionID localKey="102469176|OMIM:605373" />
        <ClinVarAccession Accession="SCV004018544" DateUpdated="2023-07-29" DateCreated="2023-07-29" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" OrgAbbreviation="MGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="1" alternateAllele="G" referenceAllele="GAA" start="161298214" stop="161298216" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">102469176</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605373" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13707487</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7519804" TraitType="Disease" MappingType="XRef" MappingValue="605373" MappingRef="OMIM">
        <MedGen CUI="C1854336" Name="Paragangliomas 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

